MedTrace Logo

Acetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow

NCT01750723 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2013-07-09

No results posted yet for this study

Summary

In this study the investigators will research the hypothesis that the drug Acetazolamide induce headache and dilation of cerebral arteries and increase the cerebral blood flow in the areas of the brain supplied by these arteries.

Conditions

Interventions

DRUG

Acetazolamide

1 g diluted in 10 ml saline, i.v. bolus injection.

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Principal Investigators

  • Nanna Arngrim, MD · Danish Headache Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01750723 on ClinicalTrials.gov